ly3437943 retatrutide 雷塔鲁肽；Retatrutide；LY3437943 Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist

& Weisz, P

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication

For NAION, the risk appears higher with GLP-1 users who are obese and diabetic, though the available early data is incomplete. He believes the risk may be higher in patients with small optic nerve cups, sometimes described as a disc at risk. Regarding neovascular age-related macular degeneration, he said signals exist, though causality has not been established

Patients benefit from enhanced engagement and real-time monitoring, fostering adherence to treatment protocols and enabling a data-driven approach to long-term care